Study of Parkinson's Early Stage With Deferiprone

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 12, 2016

Primary Completion Date

August 2, 2019

Study Completion Date

September 4, 2019

Conditions
Parkinson's Disease
Interventions
DRUG

Deferiprone

600 mg tablets

DRUG

Placebo

Tablets that match the deferiprone tablets in appearance

Trial Locations (20)

Unknown

Toronto Western Hospital, Toronto

CHU de Bordeaux, Centre Expert Parkinson, Bordeaux

Hôpital Henri Mondor, Créteil

Centre Hospitalier Régional Universitaire de Lille, Hôpital Roger Salengro, Lille

CHU Dupuytren, Limoges

Hôpital Neurologique Pierre Wertheimer, Lyon

CHRU de Montpellier - Hôpital Gui de Chauliac, Montpellier

CHU Pontchaillou, Rennes

CHU Charles Nicoll - Rouen, Rouen

Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, Strasbourg

CHU Purpan, Hôpital Pierre Paul Riquet, Toulouse

Heinriche-Heine Universität Düsseldorf, Düsseldorf

UKSH Campus Kiel, Neurologie, Kiel

Universitätsklinikum Gießen und Marburg GmbH, Marburg

Klinikum rechts der Isar, Munich

Royal Devon & Exeter Hospital, Exeter

Fairfield General Hospital, Bury

Charing Cross Hospital, London

Newcastle Clinical Ageing Research Unit, Newcastle upon Tyne

Derriford Hospital, Plymouth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ApoPharma

INDUSTRY